Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07124546) titled 'Acceptance and Commitment Therapy (ACT-HBC) for the Improvement of Cancer Distress in Patients With Hepatobiliary Cancers' on Aug. 8.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Supportive Care. Masking: None (Open Label).
Primary Sponsor: Mayo Clinic
Condition:
Malignant Hepatobiliary Neoplasm
Intervention:
Behavioral: Acceptance and Commitment Therapy
Other: Questionnaire Administration
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: May 28, 2025
Target Sample Size: 60
Countries of Recruitment:
United Stat...